| Control group | Intervention group | beta | 95% CI |
---|---|---|---|---|
LDL-C (mmol/l, mean ± SD) Baseline 12 months Difference | N = 105 3.7 (1.2) 3.6 (1.2) −0.1 | N = 128 3.6 (1.3) 3.5 (1.1) −0.1 | −0.20 | −0.40-0.03 |
HDL-C (mmol/l, mean ± SD) Baseline 12 months Difference | N = 143 1.2 (0.4) 1.2 (0.4) 0 | N = 169 1.2 (0.4) 1.2 (0.4) 0 | 0.02 | −0.04-0.08 |
TC (mmol/l, mean ± SD) Baseline 12 months Difference | N = 146 5.2 (1.2) 5.1 (1.2) −0.1 | N = 169 5.3 (1.4) 5.2 (1.2) −0.1 | −0.04 | −0.25-0.18 |
Triglycerides (mmol/l, mean ± SD) Baseline 12 months Difference | N = 110 1.3 (0.7) 1.2 (0.6) −0.1 | N = 128 1.2 (0.6) 1.3 (0.7) +0.1 | 0.08 | −0.08-0.23 |
Systolic blood pressure (mmHg, mean ± SD) Baseline 12 months Difference | N = 143 126.3 (15.7) 125.2 (14.4) −1.1 | N = 169 123.0 (14.4) 123.0 (14.1) 0 | 0.003 | −2.28-2.28 |
Glucose (mmol/l, mean ± SD) Baseline 12 months Difference | N = 145 4.9 (1.0) 4.8 (0.8) −0.1 | N = 169 4.9 (0.8) 4.7 (0.7) −0.2 | −0.06 | −0.19-0.07 |
BMI (kg/m2, mean ± SD) Baseline 12 months Difference | N = 147 27.1 (5.4) 27.1 (5.2) 0 | N = 167 25.9 (4.5) 25.8 (4.4) −0.1 | −0.18 | −0.43-0.07 |
Waist circumference (cm, mean ± SD) Baseline 12 months Difference | N = 146 89.9 (14.5) 89.9 (14.3) 0 | N = 165 86.4 (11.9) 86.1 (11.5) −0.3 | −0.54 | −1.45-0.40 |